We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Motor System Impairment Device Evaluates Tremors

By Labmedica staff writers
Posted on 23 Jan 2008
A device is being developed that will allow doctors to easily evaluate the degree and type of the tremors caused in the upper limbs by some neurologic disorders.

Called a Dimeter, the system makes it easier for doctors and other health professionals to objectively evaluate the tremors exhibited in the hands and fingers of patients affected by some disorders that impair their motor skills, such as Parkinson, amyotrophic lateral sclerosis, or Charcot-Marie-Tooth disease.

The device uses an electromechanical apparatus that is controlled by the hand or finger of the affected patient and registers the movement and the forces that are generated. More...
Together with a computer monitor, doctors execute a series of virtual static and motion tests, such as trying to keep the hand at rest, or describing a set movement, like a straight line or a spiral. In any of these tests, a weight can be added to the patient to evaluate the effect on the tremor while the system constantly monitors and records each movement.

The computer gathers the data and processes it to provide the doctor with the information needed for the patient's evaluation in a numeric or graphic format to the level of detail required. This report is objective and precise and enables doctors to adjust their diagnosis of the condition and monitor the progression of the disease, or the effectiveness of the treatment.

The device was developed by scientists from the Universidad Politécnica de Madrid (UPM; Madrid, Spain) and colleagues Antonio Barrientos and Roberto González from the Grupo de Investigación en Robótica y Cibernética of the UPM, with the collaboration of the Centro Estatal de Autonomía Personal y Ayudas Técnicas (CEAPAT) of the Instituto de Mayores y Servicios Sociales (IMSERSO; Ceuta, Spain)


Related Links:
Universidad Politécnica de Madrid
Instituto de Mayores y Servicios Sociales

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Blood Ammonia Test Analyzer
DRI-CHEM NX10N
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.